Navigation Links
Tone Deafness Explained, from the Harvard Health Letter
Date:8/23/2007

BOSTON, Aug. 23 /PRNewswire-USNewswire/ -- Do people cringe when you sing? You've got company. But researchers have found that only 1 in 20 people truly has amusia, the technical term for tone deafness. Tests have shown that some people with bad singing voices hear music just fine. Amusics are a smaller group with a perceptual problem: They can't pick out differences in pitch or follow the simplest tunes, reports the September 2007 issue of the Harvard Health Letter.

Brain scans haven't revealed major anatomical differences in amusics, but more sophisticated tests have uncovered some subtle variations. In a study comparing amusics to people with normal musical ability, researchers used a brain imaging and statistical technique to measure the density of the white matter (which consists of connecting nerve fibers) between the right frontal lobe, where higher thinking occurs, and the right temporal lobes, where basic processing of sound occurs. The white matter of the amusics was thinner, which suggests a weaker connection. Moreover, the worse the tone deafness, the thinner the white matter.

Some experts believe there's a great deal of overlap between how the brain handles music and how it handles speech, which also has elements of pitch and rhythm. Others, though, believe that musical perception and thinking occur separately from other functions, and that our brains are predisposed toward developing centers and networks dedicated exclusively to music.

If you want to test your ability to perceive music, the Harvard Health Letter refers readers to an online test at http://www.delosis.com/listening developed by researchers at the University of Newcastle-upon-Tyne in England.

Also in this issue:

-- Benefits of unsaturated fat

-- New types of lenses for cataract surgery

-- Thyroid hormone not a good means for weight loss

-- By the way doctor: Quitting smoking and getting a cough; cellulitis

explained.

The Harvard Health Letter is available from Harvard Health Publications, the publishing division of Harvard Medical School, for $28 per year. Subscribe at http://www.health.harvard.edu/health or by calling 1-877-649-9457 (toll free).

Media: Contact Christine Junge at Christine_Junge@hms.harvard.edu for a complimentary copy of the newsletter, or to receive our press releases directly.


'/>"/>
SOURCE Harvard Health Letter
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Antidepressant Use May Boost Fracture Risk, From Harvard Womens Health Watch
2. Bipolar Disorder in Children Difficult to Diagnose, Reports the Harvard Mental Health Letter
3. Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance
4. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
5. Nationwide MRSA Prevalence Study to Demonstrate Full Scope of Superbug Threat Facing U.S. Healthcare Facilities and Patients
6. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
7. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
8. FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations, FDA Regulations
9. New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory Properties and Increased Health Benefits
10. Actilyse (alteplase) Recommended by National Institute for Health and Clinical Excellence for Treatment of Acute Ischaemic Stroke
11. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
(Date:4/20/2017)... Research and Markets has announced the ... Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market ... Low drug registration cost in Latin American countries and ...
Breaking Medicine Technology:
(Date:4/24/2017)... , ... April 24, 2017 , ... ... of unique liquid food supplements, announced its popular products are now available for ... , ALP Nutrition® prioritizes the use of premium natural ingredients in making all ...
(Date:4/24/2017)... ... April 24, 2017 , ... Salus ... announces the company’s VideoMedicine mobile platform has launched Quick Care, a new service ... day, Quick Care provides patients with the option to request and begin a ...
(Date:4/24/2017)... ... April 24, 2017 , ... In 2017, up to ... approximately 25,000 of them will be malignant.(1) As research into precision medicine continues, ... healthcare model in the diagnosis and treatment of brain tumors. Healthcare facilities that ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, ... HIV because it is not known to have significant interactions with antiretroviral therapy ... both lower cholesterol levels and dampen inflammation in the bloodstream. , While lowering ...
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often perform the ... for lab operators and management to assess these processes with a critical eye—particularly ... unnecessary actions. , Created with the help of both internal and external ...
Breaking Medicine News(10 mins):